Finance

Lists
RKV:CVE
Rakovina Therapeutics Inc
CA$0.25
0.00%
(0.00) 1D
Oct 6, 3:54:29 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for RKV...
Mkt. cap
11.09M
Avg. vol.
28.14K
Volume
0.00
52-wk high
CA$0.32
52-wk low
CA$0.08
EPS
-CA$0.32
Beta
0.53
Shares outstanding
24.41M
Mkt. cap
11.09M
Avg. vol.
28.14K
Volume
0.00
52-wk high
CA$0.32
52-wk low
CA$0.08
EPS
-CA$0.32
Beta
0.53
Shares outstanding
24.41M
News stories
From web sources and news partners
About Rakovina Therapeutics Inc
CEO-
Employees-
Founded2019
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websiterakovinatherapeutics.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.10M
828.93K
1.03M
1.13M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
539.17K
972.87K
443.99K
450.70K
Operating expense
1.64M
1.80M
1.48M
1.58M
Total operating expenses
1.64M
1.80M
1.48M
1.58M
Operating income
-1.64M
-1.80M
-1.48M
-1.58M
Other non operating income
-
1.00
-
-
EBT including unusual items
-1.78M
-1.89M
-1.68M
-1.73M
EBT excluding unusual items
-1.78M
-1.91M
-1.58M
-1.73M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.78M
-1.89M
-1.68M
-1.73M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
773.00
-
8.35K
Interest expense
-139.75K
-108.48K
-101.81K
-154.53K
Net interest expenses
-139.75K
-107.70K
-101.81K
-146.18K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.51M
-1.67M
-1.34M
-1.44M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps